18F-FDG PET/CT as predictive and prognostic factor in esophageal cancer treated with combined modality treatment
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1864-6433
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
18F-FDG PET/CT as predictive and prognostic factor in esophageal cancer treated with combined modality treatment ; volume:36 ; number:5 ; day:11 ; month:3 ; year:2022 ; pages:450-459 ; date:5.2022
Annals of nuclear medicine ; 36, Heft 5 (11.3.2022), 450-459, 5.2022
- Urheber
-
Krengli, Marco
Ferrara, Eleonora
Guaschino, Riccardo
Puta, Erinda
Turri, Lucia
Luciani, Ilaria
Sacchetti, Gian Mauro
Franco, Pierfrancesco
Brambilla, Marco
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s12149-022-01733-9
- URN
-
urn:nbn:de:101:1-2022070209083152516960
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:33 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Krengli, Marco
- Ferrara, Eleonora
- Guaschino, Riccardo
- Puta, Erinda
- Turri, Lucia
- Luciani, Ilaria
- Sacchetti, Gian Mauro
- Franco, Pierfrancesco
- Brambilla, Marco
- SpringerLink (Online service)
Ähnliche Objekte (12)
Prognostic values of mid-radiotherapy 18F-FDG PET/CT in patients with esophageal cancer
Amelanotic melanoma detected by 18F-FDG PET-CT
18F-FDG PET-CT in Fitz-Hugh-Curtis Syndrome
A dedicated paediatric [18F]FDG PET/CT dosage regimen
Risikostratifizierung des rezidivierenden Mammakarzinoms mittels integrierter [18F]FDG PET/CT
SMARCA4-deficient thoracic tumor detected by [18F]FDG PET/CT
Heterogeneous imaging features of Aspergillosis at 18F-FDG PET/CT
Atypical Muscular Sarcoidosis Involvement Revealed by 18F-FDG PET/CT
Integrating 18F-FDG PET/CT radiomics and body composition for enhanced prognostic assessment in patients with esophageal cancer
Benefit of [18F]-FDG PET/CT for treatment-naïve nasopharyngeal carcinoma
Primary mesenchymal tumors of the prostate:18F FDG PET/CT findings
18F-FDG PET/CT in therapy response assessment: oligometastatic colorectal cancer
Prognostic values of mid-radiotherapy 18F-FDG PET/CT in patients with esophageal cancer
Amelanotic melanoma detected by 18F-FDG PET-CT
18F-FDG PET-CT in Fitz-Hugh-Curtis Syndrome
A dedicated paediatric [18F]FDG PET/CT dosage regimen
Risikostratifizierung des rezidivierenden Mammakarzinoms mittels integrierter [18F]FDG PET/CT
SMARCA4-deficient thoracic tumor detected by [18F]FDG PET/CT
Heterogeneous imaging features of Aspergillosis at 18F-FDG PET/CT
Atypical Muscular Sarcoidosis Involvement Revealed by 18F-FDG PET/CT
Integrating 18F-FDG PET/CT radiomics and body composition for enhanced prognostic assessment in patients with esophageal cancer
Benefit of [18F]-FDG PET/CT for treatment-naïve nasopharyngeal carcinoma
Primary mesenchymal tumors of the prostate:18F FDG PET/CT findings
18F-FDG PET/CT in therapy response assessment: oligometastatic colorectal cancer
Prognostic values of mid-radiotherapy 18F-FDG PET/CT in patients with esophageal cancer
Amelanotic melanoma detected by 18F-FDG PET-CT
18F-FDG PET-CT in Fitz-Hugh-Curtis Syndrome
A dedicated paediatric [18F]FDG PET/CT dosage regimen
Risikostratifizierung des rezidivierenden Mammakarzinoms mittels integrierter [18F]FDG PET/CT
SMARCA4-deficient thoracic tumor detected by [18F]FDG PET/CT
Heterogeneous imaging features of Aspergillosis at 18F-FDG PET/CT
Atypical Muscular Sarcoidosis Involvement Revealed by 18F-FDG PET/CT
Integrating 18F-FDG PET/CT radiomics and body composition for enhanced prognostic assessment in patients with esophageal cancer
Benefit of [18F]-FDG PET/CT for treatment-naïve nasopharyngeal carcinoma
Primary mesenchymal tumors of the prostate:18F FDG PET/CT findings